Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Who should be really considered as a poor mobilizer in the plerixafor era?
Andreola G, Vanazzi A, Radice D, Babic A, Rabascio C, Negri M, Martinelli G, Laszlo D. Andreola G, et al. Among authors: laszlo d. Transfus Apher Sci. 2012 Aug;47(1):27-32. doi: 10.1016/j.transci.2012.03.004. Epub 2012 Apr 4. Transfus Apher Sci. 2012. PMID: 22480954
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma.
Montoro J, Andreola G, Gardellini A, Babic A, Negri M, Frungillo N, Martinelli G, Laszlo D. Montoro J, et al. Among authors: laszlo d. Transfus Apher Sci. 2014 Jun;50(3):411-4. doi: 10.1016/j.transci.2014.03.006. Epub 2014 Apr 4. Transfus Apher Sci. 2014. PMID: 24751603
Plerixafor: what we still have to learn.
Lanza F, Gardellini A, Laszlo D, Martino M. Lanza F, et al. Among authors: laszlo d. Expert Opin Biol Ther. 2015 Feb;15(2):143-7. doi: 10.1517/14712598.2015.971750. Epub 2014 Oct 15. Expert Opin Biol Ther. 2015. PMID: 25315706
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.
Bertazzoni P, Rabascio C, Gigli F, Calabrese L, Radice D, Calleri A, Gregato G, Negri M, Liptrott SJ, Bassi S, Nassi L, Sammassimo S, Laszlo D, Preda L, Pruneri G, Orlando L, Martinelli G. Bertazzoni P, et al. Among authors: laszlo d. Leuk Lymphoma. 2010 Aug;51(8):1485-93. doi: 10.3109/10428194.2010.495799. Leuk Lymphoma. 2010. PMID: 20578816
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
Lanza F, Lemoli RM, Olivieri A, Laszlo D, Martino M, Specchia G, Pavone V, Imola M, Pasini A, Milone G, Scortechini I, Todisco E, Guggiari E, Cascavilla N, Martinelli G, Rambaldi A, Bosi A. Lanza F, et al. Among authors: laszlo d. Transfusion. 2014 Feb;54(2):331-9. doi: 10.1111/trf.12265. Epub 2013 Jun 19. Transfusion. 2014. PMID: 23781769
Core needle biopsy as a front line diagnostic approach for lymphoma patients.
Pruneri G, Gigli F, Rafaniello Raviele P, Gardellini A, Raimondi S, De Fiori E, Preda L, Viale G, Martinelli G, Laszlo D. Pruneri G, et al. Among authors: laszlo d. Hematol Oncol. 2015 Dec;33(4):247-9. doi: 10.1002/hon.2150. Epub 2014 Jul 2. Hematol Oncol. 2015. PMID: 24986739 No abstract available.
139 results